| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bff91d73c9ac27af8ff0590d22a1a28 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3334
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3672
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3696 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 |
| filingDate |
1995-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1997-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fb9e9c006fd41d67bb787bfd8687e66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ee55c348f53b1355bb2574060084e76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3507d463cf8af4df48856a54896eec54 |
| publicationDate |
1997-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5676645-A |
| titleOfInvention |
Method and apparatus for controlling concentrations in vivos and in tubing systems |
| abstract |
A method and apparatus for maximizing the total amount of blood processed during an apheresis procedure by optimizing the concentration of anticoagulant in a donor/patient and the associated extracorporeal tubing set is provided. A simplified model of an anticoagulant accumulation in a donor/patient's body is used to calculate an optimal anticoagulant infusion rate profile to the donor/patient during a blood processing procedure. A maximum acceptable anticoagulant concentration in the donor/patient acts as an upper limit on the rate at which anticoagulant may be infused to the donor/patient using the optimized infusion rate profile. A minimum acceptable anticoagulant level acts as a lower limit in optimally controlling the anticoagulant concentration in the extracorporeal tubing set. Both the maximum acceptable anticoagulant level in the donor/patient and the minimum acceptable anticoagulant level in the extracorporeal tubing set may be customized for a specific donor/patient thereby allowing the optimized infusion rate profile and the extracorporeal tubing set anticoagulant concentration to be customized for the specific patient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012132574-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013304020-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9593678-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10537671-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10449280-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10576194-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3705145-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9138526-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012143116-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9494150-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5833866-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463774-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6007725-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11033671-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364329-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9005150-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9713667-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11752248-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9561318-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9561317-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011266221-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9603985-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9494151-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11666690-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9555179-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10195330-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11568043-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10682450-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9517295-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008200859-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9084855-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6391300-B1 |
| priorityDate |
1992-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |